Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts - PubMed (original) (raw)

Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts

David A Nielsen et al. Hum Genet. 2010 Jun.

Abstract

The mu-opioid receptor is the site of action of many endogenous opioids as well as opiates. We hypothesize that differences in DNA methylation of specific CpG dinucleotides between former severe heroin addicts in methadone maintenance treatment and control subjects will depend, in part, upon ethnicity. DNA methylation analysis of the mu-opioid receptor gene (OPRM1) promoter region was performed on African-Americans (118 cases, 80 controls) and Hispanics (142 cases, 61 controls) and these were compared with a similar Caucasian cohort from our earlier study. In controls, a higher methylation level was found in the African-Americans compared with the Hispanics or Caucasians. Significant experiment-wise differences in methylation levels were found at the -25 and +12 CpG sites in the controls among the three ethnicities. The overall methylation level of the CpG sites were significantly higher in the former heroin addicts when compared with the controls (point-wise P = 0.0457). However, in the African-Americans, the degree of methylation was significantly decreased experiment-wise in the former heroin addicts at the +12 CpG site (P = 0.0032, Bonferroni corrected general estimating equations). In Hispanics, the degree of methylation was increased in the former heroin addicts at the -25 (P < 0.001, experiment-wise), -14 (P = 0.001, experiment-wise), and +27 (P < 0.001, experiment-wise) CpG sites. These changes in methylation of the OPRM1 promoter region may lead to altered expression of the mu-opioid receptor gene in the lymphocytes of former heroin addicts who are stabilized in methadone maintenance treatment.

PubMed Disclaimer

Cited by

Ethnicity interacts with the OPRM1 gene in experimental pain sensitivity.
Hastie BA, Riley JL 3rd, Kaplan L, Herrera DG, Campbell CM, Virtusio K, Mogil JS, Wallace MR, Fillingim RB. Hastie BA, et al. Pain. 2012 Aug;153(8):1610-1619. doi: 10.1016/j.pain.2012.03.022. Epub 2012 Jun 18. Pain. 2012. PMID: 22717102 Free PMC article. Clinical Trial.
Gender Interacts with Opioid Receptor Polymorphism A118G and Serotonin Receptor Polymorphism -1438 A/G on Speed-Dating Success.
Wu K, Chen C, Moyzis RK, Greenberger E, Yu Z. Wu K, et al. Hum Nat. 2016 Sep;27(3):244-60. doi: 10.1007/s12110-016-9257-8. Hum Nat. 2016. PMID: 27193909
Novel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome.
McLemore GL, Lewis T, Jones CH, Gauda EB. McLemore GL, et al. Semin Fetal Neonatal Med. 2013 Feb;18(1):35-41. doi: 10.1016/j.siny.2012.09.002. Epub 2012 Oct 9. Semin Fetal Neonatal Med. 2013. PMID: 23059064 Free PMC article. Review.
Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts.
Chorbov VM, Todorov AA, Lynskey MT, Cicero TJ. Chorbov VM, et al. J Opioid Manag. 2011 Jul-Aug;7(4):258-64. doi: 10.5055/jom.2011.0067. J Opioid Manag. 2011. PMID: 21957825 Free PMC article.
Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome.
Wachman EM, Hayes MJ, Lester BM, Terrin N, Brown MS, Nielsen DA, Davis JM. Wachman EM, et al. J Pediatr. 2014 Sep;165(3):472-8. doi: 10.1016/j.jpeds.2014.05.040. Epub 2014 Jul 1. J Pediatr. 2014. PMID: 24996986 Free PMC article.

References

1. Alikhani-Koopaei R, Fouladkou F, Frey FJ, Frey BM. Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. J Clin Invest. 2004;114:1146–1157. - PMC - PubMed
1. Ballestar E, Wolffe AP. Methyl-CpG-binding proteins. Targeting specific gene repression. Eur J Biochem. 2001;268:1–6. - PubMed
1. Bleich S, Lenz B, Ziegenbein M, Beutler S, Frieling H, Kornhuber J, Bonsch D. Epigenetic DNA hypermethylation of the HERP gene promoter induces down-regulation of its mRNA expression in patients with alcohol dependence. Alcohol Clin Exp Res. 2006;30:587–591. - PubMed
1. Bonsch D, Lenz B, Reulbach U, Kornhuber J, Bleich S. Homocysteine associated genomic DNA hypermethylation in patients with chronic alcoholism. J Neural Transm. 2004;111:1611–1616. - PubMed
1. Bonsch D, Lenz B, Kornhuber J, Bleich S. DNA hypermethylation of the alpha synuclein promoter in patients with alcoholism. Neuroreport. 2005;16:167–170. - PubMed

Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts - PubMed (original) (raw)